Get the Stockscreener App
7.70
16.49%
1.09
Trinity Biotech Plc Adr Stock (TRIB) Forecast
The Trinity Biotech Plc Adr (TRIB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.00, representing a +42.91% increase from the current price of $7.70. The highest analyst price target is $14.13, and the lowest is $7.8736.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TRIB Price Target
Average 67.79
(+780.36% Upside)
Is Trinity Biotech Plc Adr (TRIB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.80 | Neutral |
| STOCH(9,6) | 59.55 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.4662 | Buy |
| ADX(14) | 16.70 | Neutral |
| William %R | -19.70 | Sell |
| CCI(14) | 115.79 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.5425
Buy
|
6.7564
Buy
|
| MA20 |
6.7147
Buy
|
6.973
Buy
|
| MA50 |
8.6967
Sell
|
8.463
Sell
|
| MA100 |
11.52
Sell
|
11.11
Sell
|
| MA200 |
16.25
Sell
|
15.53
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, TRIB could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on TRIB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 53.8 indicates that TRIB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 59.55 indicates that TRIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that TRIB is oversold. This suggests that TRIB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.7 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 115.79 indicates that TRIB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term TRIB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Trinity Biotech Plc Adr financial reports and earnings history, Trinity Biotech Plc Adr (TRIB) stock could reach $76.29 by 2030, $468.16 by 2040 and $1,175.68 by 2050. See the projected annual prices until 2050 of the Trinity Biotech Plc Adr stock below:
- Trinity Biotech Plc Adr (TRIB) is expected to reach an average price of $250.88 in 2035, with a high prediction of $269.11 and a low estimate of $258.55. This indicates an $3,158% rise from the last recorded price of $7.70.
- Trinity Biotech Plc Adr (TRIB) stock is projected to chart a bullish course in 2040, with an average price target of $450.13, representing an $5,746% surge from its current level. The forecast ranges from a conservative $469.73 to a sky-high $468.16.
- Our analysts predict Trinity Biotech Plc Adr (TRIB) to jump 9,862% by 2045, soaring from $754.05 to an average price of $767.05, potentially reaching $746.43. While $754.05 is the low estimate, the potential upside is significant.
- Trinity Biotech Plc Adr (TRIB) stock is expected to climb by 2050, reaching an average of $1,136.01, a $14,653% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,175.68 and $1,160.01, respectively, highlighting the market's uncertainty.
Trinity Biotech Plc Adr Stock (TRIB) Year by Year Forecast
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2026
The predicted value for Trinity Biotech Plc Adr (TRIB) in 2026 is set at an average of $27.59. Estimates vary from a peak of $52.31 to a trough of $2.8818, indicating an +258.37% surge from the present price of $7.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $20.34 | $7.8736 | $14.13 | +164.17% |
| December, 2026 | $56.81 | $46.33 | $52.31 | +637.77% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Trinity Biotech Plc Adr (TRIB) is $89.84, with a high forecast of $127.70 and a low forecast of $51.99. This indicates an +1,067% increase from the last price of $7.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $93.28 | $85.80 | $81.28 | +1,111% |
| February, 2027 | $116.24 | $116.24 | $109.26 | +1,410% |
| March, 2027 | $130.70 | $122.73 | $127.70 | +1,597% |
| April, 2027 | $116.17 | $121.68 | $119.19 | +1,409% |
| May, 2027 | $81.13 | $97.57 | $107.66 | +953.60% |
| June, 2027 | $54.59 | $66.59 | $78.62 | +609.02% |
| July, 2027 | $59.56 | $70.09 | $65.07 | +673.53% |
| August, 2027 | $63.52 | $68.02 | $62.05 | +724.94% |
| September, 2027 | $44.49 | $51.99 | $50.51 | +477.77% |
| October, 2027 | $64.46 | $55.48 | $66.96 | +737.08% |
| November, 2027 | $66.90 | $81.45 | $66.94 | +768.82% |
| December, 2027 | $55.38 | $68.91 | $67.64 | +619.24% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2028
In 2028, Trinity Biotech Plc Adr (TRIB) is projected to reach an average price of $60.08, with a high projection of $76.31 and a low estimate of $43.85. This indicates an +680.23% rise from the last price of $7.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $42.84 | $43.85 | $31.36 | +456.37% |
| February, 2028 | $83.81 | $61.33 | $76.31 | +988.41% |
| March, 2028 | $64.77 | $70.77 | $58.30 | +741.23% |
| April, 2028 | $63.59 | $68.24 | $60.77 | +725.87% |
| May, 2028 | $88.34 | $65.73 | $72.20 | +1,047% |
| June, 2028 | $89.15 | $91.18 | $75.69 | +1,058% |
| July, 2028 | $66.13 | $62.14 | $62.23 | +758.79% |
| August, 2028 | $47.84 | $71.09 | $62.12 | +521.35% |
| September, 2028 | $72.66 | $59.59 | $51.57 | +843.59% |
| October, 2028 | $52.83 | $53.97 | $66.05 | +586.04% |
| November, 2028 | $72.99 | $86.07 | $75.00 | +847.89% |
| December, 2028 | $83.95 | $83.98 | $74.18 | +990.32% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2029
The 2029 price forecast for Trinity Biotech Plc Adr Stock (TRIB) is $84.95 on average, with a high prediction of $114.37 and a low estimate of $55.53. This represents an +1,003% increase from the previous price of $7.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $116.41 | $91.95 | $97.92 | +1,412% |
| February, 2029 | $122.51 | $115.90 | $111.66 | +1,491% |
| March, 2029 | $93.35 | $103.85 | $114.37 | +1,112% |
| April, 2029 | $98.81 | $107.81 | $105.32 | +1,183% |
| May, 2029 | $76.77 | $91.77 | $100.32 | +897.07% |
| June, 2029 | $97.34 | $91.11 | $84.74 | +1,164% |
| July, 2029 | $96.50 | $95.41 | $94.23 | +1,153% |
| August, 2029 | $98.77 | $98.49 | $97.23 | +1,183% |
| September, 2029 | $102.23 | $99.26 | $95.44 | +1,228% |
| October, 2029 | $70.19 | $75.89 | $96.43 | +811.60% |
| November, 2029 | $41.56 | $59.26 | $75.08 | +439.75% |
| December, 2029 | $62.92 | $55.53 | $53.38 | +717.14% |
Trinity Biotech Plc Adr Stock (TRIB) Price Forecast for 2030
Trinity Biotech Plc Adr Stock (TRIB) is expected to reach an average price of $79.07 in 2030, with a high forecast of $94.56 and a low forecast of $63.59. This signifies an +926.94% surge from the last price of $7.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $83.49 | $76.01 | $76.29 | +984.24% |
| February, 2030 | $91.45 | $93.88 | $94.56 | +1,088% |
| March, 2030 | $70.62 | $71.82 | $64.84 | +817.16% |
| April, 2030 | $85.38 | $72.31 | $82.38 | +1,009% |
| May, 2030 | $90.29 | $91.40 | $87.56 | +1,073% |
| June, 2030 | $85.53 | $85.92 | $84.21 | +1,011% |
| July, 2030 | $82.22 | $83.50 | $83.81 | +967.81% |
| August, 2030 | $80.01 | $81.44 | $80.10 | +939.05% |
| September, 2030 | $79.70 | $80.60 | $79.92 | +935.06% |
| October, 2030 | $69.55 | $70.07 | $73.74 | +803.28% |
| November, 2030 | $68.63 | $69.23 | $67.80 | +791.27% |
| December, 2030 | $60.59 | $63.59 | $66.17 | +686.92% |
1.86%
2.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):